Biolotus Biotech supports the development of innovative products across key therapeutic areas such as cancer, immune diseases, life threatening hemorrhages and fungal infections, fostering profitable, sustainable and strategic partnerships
Our R&D pipeline comprehend:
Innovative projects to answer to new challenges in the medical field
• Genetics (genome engineering)
• Proprietary antifungal for aspergillosis (pulmonary delivery)
• Flashclot
• Mousticide
• Market cooperation and technology transfer
• Therapeutic enzymes (biosimilars)
• Monoclonal antibodies (biosimilars)
• Diagnostic tools
Biolotus Biotech focuses on internalizing state of art production technologies for biopharmaceuticals, ensuring high quality standards